Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 3Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 54Thoracic 17Gynecologic 15CNS 13Head & Neck 10Breast 9Sarcoma 7Genitourinary 3Dermatologic 3Other solid neoplasm 2Endocrine 2Tumor-Agnostic 1Other hematologic neoplasm 1NET 1Lymphoid 1

Conditions

Stomach Neoplasms 1Ovarian Neoplasms 1Mesothelioma, Malignant 1Esophageal Neoplasms 1DMMR Colorectal Cancer 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Injections 17Cisplatin 15Carboplatin 15Oxaliplatin 11Gemcitabine 11pembrolizumab 8Capecitabine 8toripalimab 7Paclitaxel 7Etoposide 7Cyclophosphamide 7Pemetrexed 6Irinotecan 6Drug Therapy 6spartalizumab 5fludarabine 5camrelizumab 5Vincristine 5Radiotherapy 5Leucovorin 5tislelizumab 4apatinib 4anlotinib 4Interleukin-2 4Immune Checkpoint Inhibitors 4Granulocyte-Macrophage Colony-Stimulating Factor 4Fluorouracil 4Docetaxel 4Bevacizumab 4tremelimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Surgical Procedures, Operative × Other solid neoplasm × Clear all
NCT06281860 2024-02-28

PITHAC

Centre Hospitalier Universitaire Vaudois

Phase 1 Unknown
39 enrolled
BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT06262581 2024-02-16

Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery

Sun Yat-sen University

Phase 2 Unknown
40 enrolled
GastrointestinalOther solid neoplasm

DMMR Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡